← Back
Reasons are not apparent
LeMaitre Vascular Inc (NASDAQ:LMAT) reported a strong 16% sales growth in Q3 2024, driven by significant increases in grafts, patches, and carotid shunts. The company achieved a 49% EPS growth, showcasing robust profitability
+9.55% closed: 2025-02-21
Reasons are not apparent
+4.29% closed: 2024-10-12
Reasons are not apparent
+4.06% closed: 2024-11-08
Reasons are not apparent
Stock Swings
Price Drops
-5.35% 2025-03-06Price Hikes
+11.04% closed: 2024-11-05LeMaitre Vascular Inc (NASDAQ:LMAT) reported a strong 16% sales growth in Q3 2024, driven by significant increases in grafts, patches, and carotid shunts. The company achieved a 49% EPS growth, showcasing robust profitability
+9.55% closed: 2025-02-21
Reasons are not apparent
+4.29% closed: 2024-10-12
Reasons are not apparent
+4.06% closed: 2024-11-08
Reasons are not apparent